Age-Related Changes in Blood Coagulation and Fibrinolysis in Mice Fed on a High-Cholesterol Diet

Experimental Animals

Volumn 47, Issue 4, 1998, Pages 237-246

  Okazaki, Masako ^a   Morio, Yuri ^a   Iwai, Shin Ichi ^a   Miyamoto, Kei Ichi ^a   Sakamoto, Hiromi ^a   Imai, Keiko ^a   Oguchi, Katsuji ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; Fibrinogen; Hyperlipidemia; Platelet aggregation

Indexed keywords

ANTITHROMBIN III; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR;

AGING; ANIMAL; ARTICLE; BLOOD CLOTTING; CHOLESTEROL INTAKE; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE MODEL; FIBRINOLYSIS; HYPERLIPIDEMIA; INSTITUTE FOR CANCER RESEARCH MOUSE; LIVER; MALE; METABOLISM; MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; THROMBOCYTE AGGREGATION;

AGING; ANIMALS; ANTITHROMBIN III; BLOOD COAGULATION; CHOLESTEROL, DIETARY; CORONARY ARTERIOSCLEROSIS; DISEASE MODELS, ANIMAL; FIBRINOLYSIS; HYPERLIPIDEMIAS; LIVER; MALE; MICE; MICE, INBRED ICR; PLASMINOGEN; PLASMINOGEN INACTIVATORS; PLATELET AGGREGATION;

EID: 0032174023     PISSN: 13411357     EISSN: None     Source Type: Journal    
DOI: 10.1538/expanim.47.237     Document Type: Article

References (27)

1. Born, G.V.R. 1967. Effects of the numbers and sizes of platelet aggregates on the optical density of plasma. Nature 215: 1027-1029.
2. Breslow, J.L. 1996. Mouse models of atherosclerosis. Science 272: 685-688.
3. Bugge, T.H., Kombrinck, K.W., Flick, M.J., Daugherty, C.C., Danton, M.J.S., and Degen J.L. 1996. Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency. Cell 87: 709-719.
4. Chmielewska, J., Rånby, M., and Wiman, B. 1983. Evidence for a rapid inhibitor of tissue plasminogen activator in plasma. Thromb. Res. 31: 427-436.
5. Davies, M.J. 1996. The contribution of thrombosis to the clinical expression of coronary atherosclerosis. Thromb. Res. 82: 1-32.
6. DiMinno, G. and Silver, M.J. 1983. Mouse antithrombotic assay: A simple method for the evaluation of antithrombotic agents in vivo. Potentiation of antithrombotic activity by ethyl alcohol. J. Pharm. Exp. Thera. 225: 57-60.
7. Fuster, V. 1994. Mechanisms leading to myocardial infarction: Insights from studies of vascular biology. Circulation 90: 2126-2143.
8. Ichino, K., Okazaki, M., Usami, S., and Oguchi, K. 1997. Involvement of enhanced coagulation and fibrinolysis system in induction of atherosclerosis in hyperlipidemic rabbits fed on a high cholesterol diet. in vivo 11: 115-124.
9. Juhan-Vague, I. and Alessi, M.C. 1993. Plasminogen activator inhibitor 1 and atherothrombosis. Thromb. Haemostas. 70: 138-143.
10. Knofler, R., Nakano, T., Nakajima, K., Takada, Y., and Takada, A. 1995. Remnant-like lipoproteins stimulate whole blood platelet aggregation in vitro. Thromb. Res. 78: 161-171.
11. Lowry, O., Rosebrough, N., Farr, A., and Randall, R. 1951. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193: 265-275.
12. Mehta, J., Mehta, P., Lawson, D., and Saldeen, T. 1987. Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: Correlation with age and serum triglyceride concentrations. J. Am. Coll. Cardiol. 9: 263-268.
13. Okazaki, M., Suzuki, M., and Oguchi, K. 1990. Changes in coagulative and fibrinolytic activities in Triton WR-1339-induced hyperlipidemia in rats. Japan J. Pharmacol. 52: 353-361.
14. Okazaki, M., Zhang, H., Yoshida, Y., Ichino, K., Nakayama, S., and Oguchi, K. 1994. Correlation between plasma fibrinogen and serum lipids in rats with hyperlipidemia induced by cholesterol free-high fructose or high cholesterol diet. J. Nutr. Sci. Vitaminol. 40: 479-489.
15. Paigen, B., Morrow, A., Brandon, C., Mitchell, D., and Holmes, P. 1985. Variation in Susceptibility to Atherosclerosis among inbred strains of mice. Atherosclerosis 57: 65-73.
16. Peerschke, E.I. 1995. Regulation of platelet aggregation by post-fibrinogen binding events. Thromb. Haemost. 73: 862-867.
17. Resch, K.L., Ernst, E., Matrai, A., and Paulsen, H.F. 1992. Fibrinogen and viscosity as risk factors for subsequent cardiovascular events in stroke survivors. Annals Intern. Med. 117: 371-375.
18. Rånby, M., Norrman, B., and Wallén, P. 1982. A sensitive assay for tissue plasminogen activator. Thromb. Res. 27: 743-749.
19. Stewart-Phillips, J.L., Lough, L., and Skamene, E. 1988. Genetically determined susceptibility and resistance to diet-induced atherosclerosis in inbred strains of mice. J. Lab. Clin. Med. 112: 36-42.
20. Tanaka, K. and Sueishi, K. 1993. Biology of disease: The coagulation and fibrinolysis systems and atherosclerosis. Lab. Invest. 69: 5-18.
21. Tatami, R., Inoue, N., Itoh, H., Kishino, B., Koga, N., Nakashima, Y., Nishide, T., Okamura, K., Saito, Y., Teramoto, Y., Yasugi, T., Yamamoto, A., and Goto, Y. 1992. Regression of coronary atherosclerosis by combined LDL-apheresis and lipid-lowering drug therapy in patients with familial hypercholesterolemia: A multicenter study. Atherosclerosis 95: 1-13.
22. Veldman, F.J., Nair, C.H., Vorster, H.H., Vermaak, W.J.H., Jerling, J.C., Oosthuizen, W., and Venter, C.S. 1997. Dietary pectin influences fibrin network structure in hypercholesterolaemic subjects. Thrombosis Res. 86: 183-196.
23. Villeneuve, A., Berlan, M., Lafontan, M., and Montastruc, J.L. 1987. Characterization of dog platelet alpha-adrenergic receptor: Lack of in vivo down regulation by adrenergic agonist treatments. Comp. Biochem. Physiol. 81C: 181-187.
24. Wilhelmsen, L., Svardsudd, K., Korsan-Bengtsen, K., Larsson, B., Welin, L., and Tibblin, G. 1984. Fibrinogen as a risk factor for stroke and myocardial infarction. N. Engl. J. Med. 311: 501-505.
25. Wiman, B., Mellbring, G., and Rånby, M. 1983. Plasminogen activator release during venous stasis and exercise as determine by a new specific assay. Clin. Chim. Acta. 127: 227-288.
26. Winocour, P.D., Perry, D.W., and Kinlough-Rathbone, R.L. 1992. Hypersensitivity to ADP of platelets from diabetic rats associated with enhanced fibrinogen binding. Eur. J. Clin. Invest. 22: 19-23.
27. Yamaguchi, Y., Hayashi, M., Yamazoe, H., and Kunitomo, M. 1991. Preventive effects of green tea extract on lipid abnormalities in serum, liver and aorta of mice fed an atherogenic diet. Folia Pharmacol. Japon 97: 329-337.